Analysis

Fulgent Genetics, Inc. (FLGT) Stock Analysis

Fulgent Genetics, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to FLGT.

websiteFLGT/analysis/FLGT

Fulgent Genetics, Inc.

Fulgent Genetics, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to FLGT.

Stock profile

Ticker

FLGT

Asset type

Stock

Market cap

$511.2M

Sector

Health Services

Industry

Medical/Nursing Services

Currency

USD

Ticker listings

Fulgent Genetics, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • FLGT primary listing
  • A2AS4N
  • 7F0

Latest Fulgent Genetics, Inc. news

Flagship Pioneering Announces Formation of Terion, a Company Delivering the Digital Infrastructure to Power Modern Agriculture

Flagship Pioneering, a scientific innovation engine for transformative platforms and products, today announced the formation of Terion™, a new agricultural technology company cr...

Fulgent Presents Updated FID-007 Data at ASCO 2026

EL MONTE, Calif., June 01, 2026--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent" or the "Company"), a technology-based company with established laboratory services and therapeu...

Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual ...

Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual

Fulgent Reports First Quarter 2026 Financial Results

EL MONTE, Calif., May 01, 2026--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services busin...

Fulgent Selected to Present Rapid Oral Abstract Within the Head and Neck Cancer Track Session at the 2026 ASCO Annual Meeting

EL MONTE, Calif., April 22, 2026--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent" or the "Company"), a technology-based company with a well-established laboratory services busi...

Research sections

Valuation

Review valuation context for Fulgent Genetics, Inc..

Future growth

Review future growth context for Fulgent Genetics, Inc..

Past performance

Review past performance context for Fulgent Genetics, Inc..

Financial health

Review financial health context for Fulgent Genetics, Inc..

Dividend

Review dividend context for Fulgent Genetics, Inc..

Management

Review management context for Fulgent Genetics, Inc..

Ownership

Review ownership context for Fulgent Genetics, Inc..

Other information

Review other information context for Fulgent Genetics, Inc..

Community

Review community context for Fulgent Genetics, Inc..